PATENT CLAIM ANALYSIS

Application Number: 15899611
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "452000"]

Abstract:
This application provides an oral pharmaceutical composition in a solid form comprising amlodipine or a pharmaceutically acceptable salt thereof, a low dose range of dextromethorphan or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients. The composition is useful for treating hypertension.

Claim (Index 6):
The pharmaceutical composition according to  claim 5 , wherein the dextromethorphan is in an amount of 0.1-10% w/w of the pharmaceutical composition.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15141381', '13139673', '15515731', '13381534', '11930644']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7290464248096807
- 35 USC 102 Novelty (BERT): 0.4804929035365897
- Combined Prediction Score: 0.7041910726823717
- Mean Citation Score: 192.649486
- Max Citation Score: 216.22997
- Similarity Product: 177.3129687673008

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test